| Orange Family Medicine Inc | |
|
229 S Glassell St Orange CA 92866-1945 | |
| (714) 639-0303 | |
| (714) 639-3708 |
| Full Name | Orange Family Medicine Inc |
|---|---|
| Speciality | General Practice |
| Location | 229 S Glassell St, Orange, California |
| Authorized Official Name and Position | Alonzo Juan Flores (CEO) |
| Authorized Official Contact | 7146390303 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Orange Family Medicine Inc 229 S Glassell St Orange CA 92866-1945 Ph: (714) 639-0303 | Orange Family Medicine Inc 229 S Glassell St Orange CA 92866-1945 Ph: (714) 639-0303 |
| NPI Number | 1104120633 |
|---|---|
| Provider Enumeration Date | 12/23/2010 |
| Last Update Date | 04/13/2011 |
| Medicare PECOS PAC ID | 8325237001 |
|---|---|
| Medicare Enrollment ID | O20110111000819 |
News Archive
Aradigm Corporation ("Aradigm" or the "Company") today announced the dosing of the first patient in the ORBIT-4 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) Phase III pivotal clinical trial of Aradigm's proprietary formulation of inhaled ciprofloxacin (Pulmaquin®) for the treatment of non-cystic fibrosis bronchiectasis (non-CF BE).
Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cells-macrophages-are stimulated in response to pathogens.
A novel drug designed to lessen muscle damage from a heart attack has passed initial safety tests at the Duke Clinical Research Institute.
Ontario has one of the highest survival rates for breast cancer in the world, with nearly 90 per cent of women surviving the disease, yet, more than half a million women eligible for Ontario's Breast Screening Program (OBSP) are not getting screened.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104120633 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | C40484 (California) | Primary |
| Provider Name | Alonzo J Flores |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1518013978 PECOS PAC ID: 5496944183 Enrollment ID: I20110111000892 |
News Archive
Aradigm Corporation ("Aradigm" or the "Company") today announced the dosing of the first patient in the ORBIT-4 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) Phase III pivotal clinical trial of Aradigm's proprietary formulation of inhaled ciprofloxacin (Pulmaquin®) for the treatment of non-cystic fibrosis bronchiectasis (non-CF BE).
Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cells-macrophages-are stimulated in response to pathogens.
A novel drug designed to lessen muscle damage from a heart attack has passed initial safety tests at the Duke Clinical Research Institute.
Ontario has one of the highest survival rates for breast cancer in the world, with nearly 90 per cent of women surviving the disease, yet, more than half a million women eligible for Ontario's Breast Screening Program (OBSP) are not getting screened.
› Verified 5 days ago
News Archive
Aradigm Corporation ("Aradigm" or the "Company") today announced the dosing of the first patient in the ORBIT-4 (Once-daily Respiratory Bronchiectasis Inhalation Treatment) Phase III pivotal clinical trial of Aradigm's proprietary formulation of inhaled ciprofloxacin (Pulmaquin®) for the treatment of non-cystic fibrosis bronchiectasis (non-CF BE).
Sanford-Burnham Medical Research Institute scientists have discovered a new molecule that forms when certain white blood cells-macrophages-are stimulated in response to pathogens.
A novel drug designed to lessen muscle damage from a heart attack has passed initial safety tests at the Duke Clinical Research Institute.
Ontario has one of the highest survival rates for breast cancer in the world, with nearly 90 per cent of women surviving the disease, yet, more than half a million women eligible for Ontario's Breast Screening Program (OBSP) are not getting screened.
› Verified 5 days ago
Zhihong Acupuncture Clinic Co Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2950 N Glassell St,, Suite B, Orange, CA 92865 Phone: 714-858-0952 Fax: 714-998-6499 | |
Senior Doc Wyoming, P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2592 N Santiago Blvd, Orange, CA 92867 Phone: 855-434-7763 | |
Regenerative Medical Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 615 E Chapman Ave, Orange, CA 92866 Phone: 714-639-4012 Fax: 714-639-4018 | |
Trucare Health Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1234 W Chapman Ave, Ste# 101, Orange, CA 92868 Phone: 714-883-1604 | |
Western Hospitalists Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 655 S Main St, Ste. 306, Orange, CA 92868 Phone: 714-397-0844 | |
Geiss Med Nevada Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2592 N Santiago Blvd, Orange, CA 92867 Phone: 855-434-7763 | |
Coastal Dream Docs Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2860 N Santiago Blvd, Ste 110, Orange, CA 92867 Phone: 949-645-0000 Fax: 949-645-0003 |